SGS Recognized at 2019 CRO Leadership Awards for the Third Successive Year
SGS, a leading life sciences, pharmaceutical, clinical and bioanalytical contract solutions provider, today announced that it had been recognized for the third successive year in the annual CRO (Contract Research Organization) Leadership Awards.
The wins came in five categories - Capabilities, Compatibility, Expertise, Quality, and Reliability, and SGS also won Individual Attribute Awards in Data Quality, Meeting Overall Project Timelines, Technology for Real-Time Access to Data, Operational Excellence, and Responsiveness.
Commenting on the awards, Ed Miseta, Executive Editor, Life Science Leader said "Life Science Leader is proud to once again be working with ISR Reports to honor those CROs that have proven themselves to be the top performers in Compatibility, Capabilities, Expertise, Quality, Reliability, and Phase IV. The winners are selected by their pharma clients, who rate their CROs on 20+ different performance metrics. We believe SGS by receiving these awards this year shows that it is truly at the top of their class and is deserving of this recognition. Being a top performer in these categories demonstrates a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients."
"We are honored that once again SGS has been recognized by the biopharma industry as a reliable R&D partner with these awards," commented Johan Pype, SGS Benelux Managing Director. He added: "The awards are based on customer feedback, experience and how their expectations were met and exceeded, so for our service and scientific expertise to be acknowledged in this way validates our company philosophy, and the commitment of our very talented employees."
SGS Life Sciences provides clinical research, bioanalytical, biologics characterization, biosafety, and quality control testing. Delivering solutions in Europe and the US, SGS offers clinical trial (phase I to IV) services encompassing clinical project management and monitoring, biometrics, PK/PD modeling and simulation, and regulatory and medical affairs consultancy. SGS has its own clinical unit in Belgium and two phase I patient units based in Belgium and Hungary. SGS has a wealth of expertise in first in human (FIH) studies, human challenge testing, manufacturing challenge agents, biosimilars and complex PK/PD studies with a focus on infectious diseases, vaccines and respiratory therapeutics.
For further information, please contact:
As the world's leading inspection, verification, testing and certification company, SGS is recognized as the global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.